Faut-il moduler les contraintes de dose dans les organes à risque lors d’une irradiation en association avec un traitement anticancéreux systémique ?
Authors:
- E. JouglarEJE. Jouglar
- S. SupiotSSS. Supiot
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 24 (6-7) , 594-601
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Meta-analysis of incidence of early lung toxicity in 3-dimensional conformal irradiation of breast carcinomasRadiation Oncology, 2013
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2012
- Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialThe Lancet, 2011
- Radiation Dose–Volume Effects in the LungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiation Dose–Volume Effects in the BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiation-Associated Kidney InjuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalThe Lancet Oncology, 2010
- Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831Journal of Clinical Oncology, 2009
- Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?The Lancet Oncology, 2009
- Long-Term Treatment Sequelae After External Beam Irradiation With or Without Hormonal Manipulation for Adenocarcinoma of the Prostate: Analysis of Radiation Therapy Oncology Group Studies 85-31, 86-10, and 92-02International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008